Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-EN Version v7-EN
Language English English
Date Updated 2022-05-26 2022-05-25
Drug Identification Number 02243644 02243644
Brand name KALETRA KALETRA
Common or Proper name Lopinavir/ritonavir oral solution Lopinavir/ritonavir oral solution
Company Name ABBVIE CORPORATION ABBVIE CORPORATION
Ingredients RITONAVIR LOPINAVIR RITONAVIR LOPINAVIR
Strength(s) 100MG 400MG 100MG 400MG
Dosage form(s) SOLUTION SOLUTION
Route of administration ORAL ORAL ORAL ORAL
Packaging size 160mL bottle 160mL bottle
ATC code J05AR J05AR
ATC description DIRECT ACTING ANTIVIRALS DIRECT ACTING ANTIVIRALS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2022-05-03 2022-05-03
Actual start date 2022-05-03 2022-05-03
Estimated end date 2022-06-02 2022-06-02
Actual end date 2022-05-25 2022-05-25
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments As a result of an increase in demand, we are closely monitoring our inventory for Kaletra Oral Solution 80mg/20 mg, 160mL. KALETRA oral solution (80/20 mg/mL) continues to be available, however current stock available is short-dated, expiring June 1, 2022. KALETRA film-coated tablets (100/25mg) and KALETRA film-coated tablets (200/50 mg) continue to be available. Should you have any questions, please contact our Customer Service Department at 1-888-704-8270. As a result of an increase in demand, we are closely monitoring our inventory for Kaletra Oral Solution 80mg/20 mg, 160mL. KALETRA oral solution (80/20 mg/mL) continues to be available, however current stock available is short-dated, expiring June 1, 2022. KALETRA film-coated tablets (100/25mg) and KALETRA film-coated tablets (200/50 mg) continue to be available. Should you have any questions, please contact our Customer Service Department at 1-888-704-8270.
Health Canada comments